Low-dose naltrexone for treatment of pain in patients with fibromyalgia: a randomized, double-blind, placebo-controlled, crossover study
Abstract. Introduction:. Fibromyalgia (FM) is a chronic fluctuating, nociplastic pain condition. Naltrexone is a µ-opioid-receptor antagonist; preliminary studies have indicated a pain-relieving effect of low-dose naltrexone (LDN) in patients with FM. The impetus for studying LDN is the assumption o...
| Main Authors: | , , , , , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
Wolters Kluwer
2023-08-01
|
| 叢編: | PAIN Reports |
| 在線閱讀: | http://journals.lww.com/painrpts/fulltext/10.1097/PR9.0000000000001080 |